FIELD: medicine, chemical- -pharmaceutical industry, pharmacy. SUBSTANCE: invention relates to pharmaceutical composition eliciting cytokine and immunomodulating effect used for prophylaxis and treatment of diseases caused by disorders of immunologic functions. Addition of copolymer of 1,4-ethylenepiperazine N-oxide and (N-carboxyethyl)-1,4-ethylenepiperazinium bromide to an active substance in pharmaceutical composition consisting of at least one cytokine or conjugation with the latter allows creating the novel immunotherapeutic preparation with the enhanced effectiveness as compared with the known analogs. Advantage of invention involves the creation of preparation eliciting ability to modulate cytokine effect and it comprises new additional biological properties also. EFFECT: enhanced effectiveness of composition, valuable medicinal properties. 9 tbl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
IMMUNOMODELLING PREPARATION FOR INJECTION-FREE APPLICATION | 2001 |
|
RU2197986C2 |
CONJUGATE OF GLYCOPROTEIN, POSSESSING ERYTHROPOIETIN ACTIVITY, WITH POLY-1,4-ETHYLENEPIPERAZINE N-OXIDE DERIVATIVES (VERSIONS), PHARMACEUTICAL COMPOSITION AND METHOD OF CONJUGATE OBTAINING | 2013 |
|
RU2556378C2 |
PHARMACEUTICAL COMPOSITION STIMULATING IMMUNE RESPONSE OF LIVING BODY | 2021 |
|
RU2821633C1 |
ERYTHROPOETIN CONJUGATED WITH POLYETHYLENE GLYCOL | 2010 |
|
RU2433134C1 |
INTERFERON CONJUGATES AND METHOD FOR PRODUCTION THEREOF | 2011 |
|
RU2466138C1 |
PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF NEUROLOGIC DISEASES | 2007 |
|
RU2335296C1 |
PHARMACEUTICAL COMPOSITION CONTAINING Fc-REGION OF IMMUNOGLOBULIN AS CARRIER | 2004 |
|
RU2352583C2 |
STABILIZED COMPOSITION POSSESSING ANTIVIRAL, ANTICANCER, IMMUNOMODULATORY, ACTOPROTECTIVE, ANTIMUTAGENIC AND ANTIOXIDANT ACTIVITY | 2018 |
|
RU2690677C1 |
ERYTHROPOETIN APPLICATION | 2003 |
|
RU2305554C2 |
EXTENDED FACTOR OF HUMAN ERYTHROPOIESIS AND A THERAPEUTIC AGENT BASED THEREON | 2015 |
|
RU2664588C2 |
Authors
Dates
2004-01-27—Published
2002-01-21—Filed